Your browser doesn't support javascript.
loading
Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease".
Gallo, D; Tanda, M L; Piantanida, E.
Affiliation
  • Gallo D; From the Department of Medicine and Surgery, Endocrine Unit, University of Insubria, Varese, Italy.
  • Tanda ML; From the Department of Medicine and Surgery, Endocrine Unit, University of Insubria, Varese, Italy.
  • Piantanida E; From the Department of Medicine and Surgery, Endocrine Unit, University of Insubria, Varese, Italy.. Electronic address: eliana.piantanida@uninsubria.it.
Endocr Pract ; 26(9): 1039-1041, 2020 Sep.
Article in En | MEDLINE | ID: mdl-33471693
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antithyroid Agents / Graves Disease Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Endocr Pract Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antithyroid Agents / Graves Disease Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Endocr Pract Year: 2020 Document type: Article